Увійти

Готові списки джерел за темами / Cardio-vascular / Статті в журналах

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: Cardio-vascular.

Статті в журналах з теми "Cardio-vascular"

Автор: Grafiati

Опубліковано: 13 вересня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Cardio-vascular".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Sorokin, Alexander V., Kazuhiko Kotani, Olga Y. Bushueva, and Alexey V. Polonikov. "Antioxidant-related gene polymorphisms associated with the cardio-ankle vascular index in young Russians." Cardiology in the Young 26, no. 4 (June 17, 2015): 677–82. http://dx.doi.org/10.1017/s104795111500102x.

Повний текст джерела

Анотація:

AbstractThe cardio-ankle vascular index is a measure of arterial stiffness, whereas oxidative stress underlies arterial pathology. This study aimed to investigate the association between the cardio-ankle vascular index and antioxidant-related gene polymorphisms in young Russians. A total of 89 patients (mean age, 21.6 years) were examined by the cardio-ankle vascular index and for 15 gene polymorphisms related to antioxidant enzymes including FMO3 (flavin-containing monooxygenase 3), GPX1 (glutathione peroxidase 1), and GPX4 (glutathione peroxidase 4). A higher cardio-ankle vascular index level was detected in carriers with the KK-genotype of FMO3 polymorphism rs2266782 than in those without (mean levels: 6.2 versus 5.6, respectively, p<0.05). Similarly, a higher cardio-ankle vascular index level was seen in carriers with the CC-genotype of GPX4 polymorphism rs713041 than in those without (6.0 versus 5.5, respectively, p<0.05). We did not observe significant associations between the cardio-ankle vascular index levels and the other gene polymorphisms. Although carriers with the LL-genotype of GPX1 polymorphism rs1050450 showed a higher diastolic blood pressure level than those without, the polymorphism did not affect the cardio-ankle vascular index level. This study showed a significant association between rs2266782 and rs713041 polymorphisms and arterial stiffness, as measured by the cardio-ankle vascular index, in young Russians. The pathways utilised by antioxidant enzymes may be responsible for early arterial stiffening in the Russian population.

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Otelea, Marina Ruxandra, Mihaela Trenchea, Corina Zugravu, Razvan Hainarosie, Alexandru Stefan Rascu, and Cristian Dragos Stefanescu. "Relationship Between Intermittent Hypoxia,Nocturnal Voiding and Sleep Related Breathing Disorders." Revista de Chimie 70, no. 5 (June 15, 2019): 1539–43. http://dx.doi.org/10.37358/rc.19.5.7165.

Повний текст джерела

Анотація:

Nocturia, cardio-vascular diseases and diabetes are frequent in patients with sleep related breathing disorders. In this study, we had analyzed the influence of the intermittent hypoxia on nocturia prevalence and found that cardio-vascular diseases, obesity, age and apnea hypopnea indexpredict 27.1% of nocturia�s variance (Nagelkerke R square-=.271, c2= 68.35).In AHI [28, the chance of nocturia is 50% and the difference dependents on the presence or absence of the cardio-vascular diseases. For values of AHI ]28, the risk of nocturia becomes independent of the presence of the cardio-vascular disease.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

C, Devadawson. "Fish Consumption and Cardio Vascular Diseases in Sri Lanka." International Journal of Science and Research (IJSR) 13, no. 3 (March 5, 2024): 1838–49. http://dx.doi.org/10.21275/sr24327151256.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Groodpanta, Sumaiporn, and Urai Ieosriyoke. "Drug Induced Cardio-vascular Events." Bangkok Medical Journal 01, no. 01 (February 26, 2011): 103–5. http://dx.doi.org/10.31524/bkkmedj.2011.02.016.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Mitchell-Fearon, K., D. Willie-Tyndale, N. Waldron, D. Holder-Nevins, K. James, H. Laws, and D. Eldemire-Shearer. "Cardio-Vascular Disease and Cancer." Gerontology and Geriatric Medicine 1 (July 31, 2015): 233372141561182. http://dx.doi.org/10.1177/2333721415611821.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Yo’ldosheva, S. G., and D. A. Kasimova. "PREVENTION OF CARDIO-VASCULAR DISEASES." European Journal of Medical Genetics and Clinical Biology 1, no. 5 (May 16, 2024): 32–35. http://dx.doi.org/10.61796/jmgcb.v1i5.420.

Повний текст джерела

Анотація:

The human cardiovascular system, which was formed in the process of biological evolution, has not changed significantly throughout the history of mankind. But our way of life is very different from the way of life of our distant, and even not very distant, ancestors. Then movement, obtaining food, creating housing and all other types of activity required constant and large expenditures of muscle strength from a person. And the human circulatory system is initially oriented precisely towards such an intensely active lifestyle. For its normal functioning, for example, a person must walk at least 6 km a day, and this is daily! By our urban standards today, many people cannot afford to walk even one or two bus stops; there is no time for it

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Krajewska–Włodarczyk, Magdalena, Agnieszka Owczarczyk-Saczonek, and Waldemar Placek. "Higher Risk of Future Cardiovascular Events Among Patients with Psoriatic Arthritis Compared to Psoriatic Patients Between the Ages of 30-50." Open Dermatology Journal 12, no. 1 (February 19, 2018): 5–11. http://dx.doi.org/10.2174/187437220181201005.

Повний текст джерела

Анотація:

Introduction: Psoriasis and Psoriatic Arthritis (PsA) are chronic diseases with a number of complications that, among others, may include alterations in the cardio-vascular system. Methods: The aim of this study was to evaluate the risk of Cardiovascular Diseases (CVD) in patients with psoriasis and psoriatic arthritis between the ages of 30-50. The research covered 95 outpatients and inpatients: 51 with plaque psoriasis (23 women and 28 men) and 44 with psoriasis and psoriatic arthritis (16 women and 28 men). The risk of cardio-vascular incident was evaluated with the use of the Framingham algorithm covering the age, total cholesterol, HDL cholesterol, blood pressure, the habit of smoking and diabetes. The 10-year risk of the occurrence of a cardio-vascular incident was higher in patients with psoriatic arthritis than in patients with plaque psoriasis (9,9% vs6,2%). A high risk of cardio-vascular events was observed in 35% men with psoriatic arthritis in comparison to 11% men with only psoriasis. In patients with plaque psoriasis, the increase in the risk of cardio-vascular incident was connected with the late beginning of psoriasis; whereas in the group of patients with psoriatic arthritis, the risk of cardio-vascular incident was connected with the intensification of psoriatic lesions. Conclusion: The patients with psoriasis, especially men with psoriatic arthritis, certainly require special medical care in terms of cardio-vascular diseases prevention.

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Horinaka, Shigeo, Akihisa Yabe, Hiroshi Yagi, Kimihiko Ishimura, Hitoshi Hara, Tomoyuki Iemua, and Hiroaki Matsuoka. "Comparison of Atherosclerotic Indicators between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity." Angiology 60, no. 4 (November 17, 2008): 468–76. http://dx.doi.org/10.1177/0003319708325443.

Повний текст джерела

Анотація:

Background Aortic pulse wave velocity has been used for evaluating atherosclerosis. Recently, the development of the volume plethysmographic method has made it possible to easily measure the index of the pulse wave velocity. The brachial ankle pulse wave velocity and cardio ankle vascular index are used for estimating the extent of atherosclerosis. The diagnostic usefulness of these indexes in predicting coronary artery disease was examined. Methods The brachial ankle pulse wave velocity, the cardio ankle vascular index, and the high-sensitivity C-reactive protein were measured in 696 patients who had chest pain and underwent coronary angiography. Measurement values of brachial ankle pulse wave velocity were compared with those of cardio ankle vascular index in terms of the baseline covariates and the number of major coronary vessels involved (vessel disease). Results The brachial ankle pulse wave velocity was significantly correlated with age, systolic blood pressure, and diastolic blood pressure but not with the high-sensitivity C-reactive protein. The cardio ankle vascular index was correlated only with age and the high-sensitivity C-reactive protein. The average of both brachial ankle pulse wave velocity and cardio ankle vascular index values was greater in 3 vessel disease group than in 0 vessel disease group. The receiver operating characteristic curve showed that the diagnostic accuracy of coronary artery disease was significantly higher in the cardio ankle vascular index than in the brachial ankle pulse wave velocity (area under the curve ± standard error: 0.691 ± 0.025 vs. 0.584 ± 0.026; P < .05). Conclusions As a means of estimating the extent of atherosclerosis in large arteries, our results show that both brachial ankle pulse wave velocity and cardio ankle vascular index are useful and that cardio ankle vascular index may have some advantages in its application to patients taking blood pressure—lowering medication because of the minimum effect of blood pressure on its measurement values. The cardio ankle vascular index has increased performance over brachial ankle pulse wave velocity in predicting the coronary artery disease.

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Kudrya, O. N. "Vegetative provision of the cardio-vascular system while orthostatic sportsmen testing." Bulletin of Siberian Medicine 9, no. 3 (June 28, 2010): 75–81. http://dx.doi.org/10.20538/1682-0363-2010-3-75-81.

Повний текст джерела

Анотація:

The article includes the results of the researching vegetative provision of the cardio-vascular system activity of 314 sportsmen 9—25 years old in patience and while orthostatic testing. It was discovered that in different age periods the process of urgent the cardio-vascular system adaptation while orthostatic testing is connected with different controlling levels cardio rhythm activating.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Charak, Manik, and Aziz Ahmed. "Approach of Herbal Drugs in Treatment of Cardio Vascular Disease." International Journal of Trend in Scientific Research and Development Volume-3, Issue-4 (June 30, 2019): 70–76. http://dx.doi.org/10.31142/ijtsrd23554.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

11

Zhang, Nan, and Zhaohua Yang. "Quantum Correlated Imaging is a Promising New Technique in Medical Imaging." Translational Neuroscience and Clinics 3, no. 2 (June 2017): 63–65. http://dx.doi.org/10.18679/cn11-6030_r.2017.014.

Повний текст джерела

Анотація:

Cardio-cerebral vascular diseases are common and frequently occurring serious diseases that threaten humans. In recent years, Digital Subtraction Angiography (DSA) has played a vital role in the diagnosis and treatment of cardio-cerebral vascular diseases. However, DSA is not able to visualize intravascular structures in real time, and it is especially difficult to evaluate each layer of the vascular wall and the composition of atherosclerotic plaques with DSA. Quantum correlated imaging is a new technique that can be used to perform real-time online imaging of intravascular flow, vascular wall structure, and atherosclerotic plaque composition. Quantum correlated imaging is a promising new technique that will soon be used in the diagnosis and treatment of cardio-cerebral vascular diseases.

Стилі APA, Harvard, Vancouver, ISO та ін.

12

Bhuiyan, Alauddin, Ryo Kawasaki, Ecosse Lamoureux, Tien Y. Wong, and Kotagiri Ramamohanarao. "Retinal Vascular Features for Cardio Vascular Disease Prediction: Review." Recent Patents on Computer Sciencee 3, no. 3 (November 1, 2010): 164–75. http://dx.doi.org/10.2174/2213275911003030164.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

13

Tyurenkov, Ivan N., Valentina N. Perfilova, Alla A. Nesterova, and Yelena Glinka. "Klotho Protein and Cardio-Vascular System." Biochemistry (Moscow) 86, no. 2 (February 2021): 132–45. http://dx.doi.org/10.1134/s0006297921020024.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

14

Yahalom, Malka, Ehud Rozner, Menachem Nahir, Lev Bloch, and Yoav Turgeman. "Chest Irradiation Associated Cardio-Vascular Disease." World Journal of Cardiovascular Diseases 06, no. 06 (2016): 179–87. http://dx.doi.org/10.4236/wjcd.2016.66019.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

15

BARBARASH, N. A., and D. Yu KUVSHINOV. "Smoking and cardio -vascular risk factors." Complex Issues of Cardiovascular Diseases, no. 1 (May 8, 2016): 51–54. http://dx.doi.org/10.17802/2306-1278-2016-1-51-54.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

16

Горбачова, В. В., and О. І. Плегуца. "Obesity and Cardio-vascular Disorders: Review." Family Medicine, no. 3 (July 30, 2020): 47–51. http://dx.doi.org/10.30841/2307-5112.3.2020.211860.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

17

Opielak, Grzegorz, Barbara Madej-Czerwonka, Jakub Piotrkowicz, Łukasz Szeszko, Wojciech Dworzański, Cezary Kowalski, and Sylwia Opielak. "Antidepressant drugs and cardio-vascular system." Current Issues of Pharmacy and Medical Sciences 26, no. 2 (May 1, 2013): 144–47. http://dx.doi.org/10.12923/j.2084-980x/26.2/a.05.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

18

Bădilă, Elisabeta, Ana Maria Daraban, Emma Ţintea, Daniela Bartoş, Nicoleta Alexandru, and Adriana Georgescu. "Midkine proteins in cardio-vascular disease." European Journal of Pharmacology 762 (September 2015): 464–71. http://dx.doi.org/10.1016/j.ejphar.2015.06.040.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

19

Bartz, Dirk, Özlem Gürvit, Martina Lanzendörfer, Andreas Kopp, Andreas Küttner, and Wolfgang Straßer. "Virtual endoscopy for cardio vascular exploration." International Congress Series 1230 (June 2001): 1005–9. http://dx.doi.org/10.1016/s0531-5131(01)00175-3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

20

Nawab, S. M. "Current Trends in Cardio-vascular Surgery." Journal of Nepal Medical Association 3, no. 2 (January 1, 2003): 61–65. http://dx.doi.org/10.31729/jnma.935.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

21

Kandula, Moses, P. Karthika, and Robin Abraham. "Nurses Action towards Cardio Vascular Emergencies." Asian Journal of Nursing Education and Research 9, no. 1 (2019): 121. http://dx.doi.org/10.5958/2349-2996.2019.00024.7.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

22

Wang, Pei, Paul M. Vanhoutte, and Chao-Yu Miao. "Visfatin and Cardio–Cerebro–Vascular Disease." Journal of Cardiovascular Pharmacology 59, no. 1 (January 2012): 1–9. http://dx.doi.org/10.1097/fjc.0b013e31820eb8f6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

23

Hufford, Terry L. "The cardio-vascular construction kit: Computer-based tutoring utilizing constructive simulation of the cardio-vascular system." Computers & Education 17, no. 4 (January 1991): 305–7. http://dx.doi.org/10.1016/0360-1315(91)90104-y.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

24

Tabata, Tsuyoshi, Shuji Sato, Ruiko Ohno, Masahiro Iwakawa, Hajime Kiyokawa, Yukihiro Morinaga, Naoaki Tanji, Toshio Kinoshita, and Kazuhiro Shimizu. "Cardio-Vascular Interaction Evaluated by Speckle-Tracking Echocardiography and Cardio-Ankle Vascular Index in Hypertensive Patients." International Journal of Molecular Sciences 23, no. 22 (November 21, 2022): 14469. http://dx.doi.org/10.3390/ijms232214469.

Повний текст джерела

Анотація:

Hypertension increases arterial stiffness, leading to dysfunction and structural changes in the left atrium (LA) and left ventricle (LV). However, the effects of hypertension on the right atrium (RA) and the right ventricle are still not fully understood. The purpose of this study was to clarify whether there is an interaction not only in the left ventricular system but also in the right ventricular system in hypertensive patients with preserved LV ejection fraction. The current retrospective observational study included patients (n = 858) with some risk of metabolic abnormalities (hypertension, diabetes, and dyslipidemia) who had visited our hospital and undergone echocardiography between 2015 and 2018. Among them, we retrospectively studied 165 consecutive hypertensive patients with preserved LV ejection fraction who had echocardiography performed on the same day as a cardio-ankle vascular index (CAVI) in our hospital. The phasic function of both atria was evaluated by two-dimensional speckle-tracking echocardiography. CAVI was measured using Vasela 1500 (Fukuda Denshi®). In the univariate analysis, CAVI was significantly correlated with LA and RA conduit function (LA conduit function, r = −0.448, p = 0.0001; RA conduit function, r = −0.231, p = 0.003). A multivariate regression analysis revealed that LA and RA conduit function was independently associated with CAVI (LA, t = −5.418, p = 0.0001; RA, t = −2.113, p = 0.036). CAVI showed a possibility that the association between heart and vessels are contained from not only LA phasic function but also RA phasic function in hypertensive patients.

Стилі APA, Harvard, Vancouver, ISO та ін.

25

Philip, Ranjit, Noel Delos Santos, and Bruce Alpert. "Cardio-ankle Vascular Index As A Non-invasive Screening Tool For Cardio-vascular Disease In Youth." Pediatrics 144, no. 2_MeetingAbstract (August 1, 2019): 202. http://dx.doi.org/10.1542/peds.144.2ma3.202.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

26

Boissel, J. P., J. C. Peyrieux, and J. M. Destors. "Is It Possible to Reduce the Risk of Cardiovascular Events in Subjects Suffering from Intermittent Claudication of the Lower Limbs?" Thrombosis and Haemostasis 62, no. 02 (1989): 681–85. http://dx.doi.org/10.1055/s-0038-1646882.

Повний текст джерела

Анотація:

SummaryThis study meta-analysed randomized, double-blind, placebo controlled trials in patients with intermittent claudication of the lower limbs comparing ticlopidine to placebo in order to test the hypothesis that the drug, a pure antiplatelet agent, is able to reduce the incidence of thrombotic cardio-vascular events on atherosclerotic arteries in these patients. A highly significant reduction, from 9% to 3% (p ranging from 0.006 to 0.002), was observed for fatal or non-fatal cardio-vascular events in a total of 611 patients (301 with ticlopidine, 310 with placebo). The duration of follow-up ranged from 6 to 12 months. Side-effects, defined as withdrawal from study medication for any reason but death, cardio-vascular events or cancer, were 2.4 times more frequent in the ticlopidine treated patients as compared to placebo. We concluded that in this high risk population, prevention of cardio-vascular events is likely to be effective.

Стилі APA, Harvard, Vancouver, ISO та ін.

27

Kashukh, Ye A., and V. T. Ivashkin. "Probiotics, metabolism and the functional condition of cardio-vascular system." Russian Journal of Gastroenterology, Hepatology, Coloproctology 26, no. 1 (August 12, 2016): 8–14. http://dx.doi.org/10.22416/1382-4376-2016-26-1-8-14.

Повний текст джерела

Анотація:

The aim of review. To characterize possible relation between microbiome and cardio-vascular system structural and functional state. Key points. Along with traditional concepts on the risk factors of atherosclerosis and cardio-vascular diseases development one should take into account data on the new pathogenic mechanisms for these diseases. According to recent studies human gastrointestinal microbiome may increase cardiovascular risk due to bacterial production of proinflammatory proteins that both promote development of atherosclerosis and directly affect the heart and vessels. Probiotics, that are mainly prescribed at gastroenterological diseases, may be applied for correction of cardiovascular risk factors as well. Obtained data demonstrate that intake of certain probiotic strains may be applied as a successful treatment of atherosclerosis, systemic hypertension, metabolic syndrome and heart failure. Conclusion. Microbiome may be involved in development of cardio-vascular diseases and atherosclerosis due to metabolic symbiosis with the host. Probiotics may be applied as preventive medication for correction of metabolic disorders that result in development of cardio-vascular diseases and atherosclerosis.

Стилі APA, Harvard, Vancouver, ISO та ін.

28

Zubko, Aleksandr, Tamara Sabgaida, Viktoriya Semyonova, and Nataliya Muzykantova. "MORTALITY ASSOCIATED WITH PREVENTABLE CAUSES OF DEATHS FROM CARDIO-VASCULAR DISEASES IN THE PRE-COVID PERIOD AND DURING THE PANDEMIC IN RUSSIA." Social Aspects of Population Health 69, no. 1 (2023): 6. http://dx.doi.org/10.21045/2071-5021-2023-69-1-6.

Повний текст джерела

Анотація:

Significance. The healthcare system can manage preventable causes of death if timely and effective interventions are in place including interventions aimed at improving living conditions and lifestyle of the population. Which diseases of the circulatory system are preventable? These are chronic rheumatic heart diseases and arterial hypertension at least in ages 5-64, and cerebrovascular diseases. The updated list of treatable diseases includes ischemic heart disease originally considered as a non-manageable cause. In the pre-COVID period the mortality structure underwent quality changes in terms of diseases and age distribution since the impact of preventive measures can manifest itself both in the decreased share of preventable causes and increased life expectancy of patients with cardio-vascular diseases. Did the gain in the age structure of preventable mortality from cardio-vascular diseases (CVD) sustain during the pandemic? The purpose of the study is to analyze contribution of preventable causes to cardio-vascular diseases mortality in the pre-COVID period and during the pandemic in Russia. Material and methods. The study used ROSSTAT data (Russian Federal State Statistics Service) to analyze data on cardio-vascular diseases mortality in the Russian Federation in 1999-2021. Male and female mortality was calculated for ages 5-64 years – the age interval of preventability. Since access to health care and risk factors of cardio-vascular diseases differ among urban and rural settings, rural and urban mortality was analyzed separately. Potential years of life lost (PYLL) were calculated as the sum products of the absolute number of deaths and potential years lost in each age group divided by 10 000 population of the corresponding age. Results. In most cases, the contribution of preventable causes to cardio-vascular diseases mortality in ages 5-64 has been steadily decreasing since 2003. The share of chronic rheumatic heart diseases equaling to less than one percent in males in the beginning of the century has decreased more than 3-fold during the pandemic. Similar trends are registered in female mortality, yet at higher rates. It should be emphasized here that mortality from chronic rheumatic heart diseases has been reducing since the end of the last century including throughout the period of social and economic collapse. The contribution of arterial hypertension to cardio-vascular diseases mortality is also low. The highest contribution to cardio-vascular diseases mortality is made by ischemic heart disease. Unlike other diseases under study, its contribution is higher among male urban population. Heart failure is associated with the lowest contribution to cardio-vascular diseases mortality. During the pandemic, its share has decreased in male mortality while hardly changed in females. The contribution of cerebrovascular diseases to cardio-vascular diseases mortality has significantly decreased sustaining this decline throughout the pandemic. In general, the contribution of preventable causes to cardio-vascular diseases mortality in ages 5-64 has been steadily reducing in males from 79.9% in 2003 to 72.7% in 2019 and to 71.6% in 2021 and in females from 80.5%% to 69.5% and 69.8%, respectively. The contribution of preventable causes in male mortality is higher among urban population compared to rural one (73.1% versus 71.3% in 2019, 71.9% versus 70.7% in 2021), while mortality in urban and rural females is almost the same. Conclusion. Analysis of preventable causes of cardio-vascular diseases mortality concludes as follows: First, it is those causes that have contributed the most to the decrease in mortality; Second, at the preventability age interval, the impact of preventive measures manifests itself in changes in mortality from ischemic heart disease and cerebrovascular diseases. Third, to ensure reduction in male mortality from cerebrovascular diseases it is necessary to intensify measures aimed at preventing alcohol use. Forth, it makes sense to analyze effectiveness of measures aimed at preventing avoidable mortality from diseases of the circulatory system using PYLL-70.

Стилі APA, Harvard, Vancouver, ISO та ін.

29

C., Dr Saravanabhavan. "A New Approach for Cardio Vascular Disease Prediction Using Decision Tree." International Journal of Psychosocial Rehabilitation 24, no. 5 (May 29, 2020): 7944–52. http://dx.doi.org/10.37200/ijpr/v24i5/pr2020796.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

30

Zilov, Aleksey Vadimovich, Tatiana Borisovna Morgunova, and Anna Leont'evna Terekhova. "The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review." Diabetes mellitus 13, no. 2 (June 15, 2010): 100–104. http://dx.doi.org/10.14341/2072-0351-5684.

Повний текст джерела

Анотація:

In this systematic review the analysis of hypoglycemia and cardio-vascular events was analyzed due to therapy by SU and other secretagenes. Accordingto more then 1400 publications from 1984 to 2009 there is no clear data of increasing hypoglycemia and cardio-vascular events by using micronisedglibenklamide (glyiburide) in comparison to other medications.

Стилі APA, Harvard, Vancouver, ISO та ін.

31

Lyamina, Nadezhda P., and E. V. Kotelnikova. "The organization of remote preventive observation of patients with cardiovascular diseases on the basis of informational communication model." Health Care of the Russian Federation 60, no. 4 (May 24, 2019): 172–77. http://dx.doi.org/10.18821/0044-197x-2016-60-4-172-177.

Повний текст джерела

Анотація:

The informational communication technologies are important organizational component of implementation of measures ofprevention of cardio-vascular diseases into everyday practice. The application of informational analytical systems in the process of registration, delivery and analysis of big medical data is directed to ensuring informational and analytical support of physician and managerial decision-making in this area. The study was carried out to evaluate possibilities of application of informational communication model of remote preventive observation in the process of implementation of activities of secondary prevention by patients with cardio-vascular diseases. The Russian clinical recommendations concerning cardio-vascular diseases are the methodological foundation of developed model of preventive observation on the basis of “ReaProf. The main technical element is medical preventive counseling. The results of preliminary evaluation of effectiveness of remote observation within the framework of six months work with application of “ReaProf substantiate possibility of implementation of informational communicative technologies on the basis of “cloud" technologies for organizing of activities of secondary prevention and increasing of activity ofpatients with cardio-vascular diseases in controlling one’s own health.

Стилі APA, Harvard, Vancouver, ISO та ін.

32

Komiyama, M. "Cardio-cephalic neural crest syndrome: A novel hypothesis of vascular neurocristopathy." Interventional Neuroradiology 23, no. 6 (August 16, 2017): 572–76. http://dx.doi.org/10.1177/1591019917726093.

Повний текст джерела

Анотація:

A novel hypothesis proposes that “cardio-cephalic neural crest (NC) syndrome,” i.e. cephalic NC including cardiac NC, contributes to the concurrent occurrence of vascular diseases in the cardio- and cerebrovascular regions. NC is a transient structure present in early embryogenesis. Cephalic NC provides mesenchymal cells to the vascular media in these regions. Concurrent cardio- and cerebrovascular lesions have been reported in PHACE syndrome, ACTA2 mutation syndrome, and less frequently in the spontaneous occlusion of the circle of Willis (so-called moyamoya disease). Cardiovascular lesions in these syndromes include coarctation of the aorta, persistent truncus arteriosus, patent ductus arteriosus, and coronary artery disease, and cerebrovascular lesions include agenesis and stenosis/occlusion of the internal carotid arteries, and moyamoya phenomenon. These concurrent vascular lesions both in the cardio- and cerebrovascular regions might be related to cephalic NC. This hypothesis, although not proven, may facilitate a better understanding of the above-mentioned NC-related vascular pathologies and lead to appropriate diagnostic and therapeutic approaches for clinicians and chart future direction for researchers.

Стилі APA, Harvard, Vancouver, ISO та ін.

33

Versmissen, Jorie, Katrina M. Mirabito Colafella, Stijn L. W. Koolen, and A. H. Jan Danser. "Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension." Cardiovascular Research 115, no. 5 (February 6, 2019): 904–14. http://dx.doi.org/10.1093/cvr/cvz022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

34

Lesiak, Maciej, Ropacka-Lesiak Mariola, and Natalia Podkowa. "Hormone replacement therapy and cardio-vascular disease." Polish Gynaecology 87, no. 01 (2016): 59–64. http://dx.doi.org/10.17772/gp/61022.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

35

Nishteswar, K. "Credential evidences of Ayurvedic cardio-vascular herbs." AYU (An International Quarterly Journal of Research in Ayurveda) 35, no. 2 (2014): 111. http://dx.doi.org/10.4103/0974-8520.146194.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

36

Gawaz, Meinrad, and Rüdiger E. Scharf. "COVID-19: Cardio-pulmonary and Vascular Manifestations." Hämostaseologie 41, no. 05 (October 2021): 347–48. http://dx.doi.org/10.1055/a-1370-0231.

Повний текст джерела

Анотація:

AbstractThe COVID-19 pandemic is still threatening us, our patients, and the global health care system. Since the first outbreak at the end of 2019 in China, it became rapidly clear that a new variant of a SARS virus, SARS-CoV-2, is threatening our human society worldwide. Since then, the scientific community has accumulated an incredibly large amount of knowledge about the pathophysiology of this virus, primarily affecting the respiratory tract and, in severe cases, subsequently resulting in acute respiratory distress syndrome and multiple organ failure due to uncontrolled systemic inflammatory response syndrome.1 2

Стилі APA, Harvard, Vancouver, ISO та ін.

37

Asthana, Alok Kumar, Monika Asthana, and Payal Sharma. "PREVENTION OF CARDIO VASCULAR DISEASE THROUGH AYURVEDA." Asian Journal of Pharmaceutical Research and Development 6, no. 4 (August 23, 2018): 97–100. http://dx.doi.org/10.22270/ajprd.v6i4.379.

Повний текст джерела

Анотація:

In today's era non communicable diseases are most prevalent diseases. They are also known as chronic diseases. Cardiovascular disease (heart disease) or Hridaroga is one of them. This is a lifestyle disorder and that’s why we should always focus on a healthy lifestyle. A healthy lifestyle can reduce the risk of this lethal disease. Our various bad food habits and sedentary lifestyle are the major causes for heart disease. This article will provide all of us a brief knowledge of heart disease (hridaroga). One has correctly said “Prevention is better than cure”. So, this article will mainly focus on how we can prevent heart disease through ayurveda. Ayurveda is the best pathy to prevent lifestyle disorder. Here we will see various yoga asanas, various dietary habits, lifestyle modifications we can do to prevent the disease. Keywords: Hridaroga, hridashoola, CVD

Стилі APA, Harvard, Vancouver, ISO та ін.

38

Rostagno, Carlo, Francesca Pastorelli, Sandro Domenichetti, and Gian Franco Gensini. "Cardio-Vascular Risks Associated with Clozapine Treatment." Current Psychiatry Reviews 7, no. 3 (August 1, 2011): 170–76. http://dx.doi.org/10.2174/157340011797183148.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

39

Suzuki, Jun, Ryuji Sakakibara, Takanobu Tomaru, Fuyuki Tateno, Masahiko Kishi, Emina Ogawa, Takumi Kurosu, and Kohji Shirai. "Stroke and Cardio-ankle Vascular Stiffness Index." Journal of Stroke and Cerebrovascular Diseases 22, no. 2 (February 2013): 171–75. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2011.07.010.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

40

Konstam, Marvin A. "Heart Failure: A Cardio-Renal-Vascular Syndrome." Journal of Cardiac Failure 14, no. 7 (September 2008): S132. http://dx.doi.org/10.1016/j.cardfail.2008.07.014.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

41

Hirst, G. D. S. "Neuroeffector transmission in the cardio-vascular system." Journal of the Autonomic Nervous System 43 (April 1993): 15. http://dx.doi.org/10.1016/0165-1838(93)90137-j.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

42

Kim, W. J. "Cardio-vascular disease prevalence with sleep disorders." Sleep Medicine 64 (December 2019): S199. http://dx.doi.org/10.1016/j.sleep.2019.11.553.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

43

Richard Conti, C. "Viagra®, the latest cardio-vascular drug." Clinical Cardiology 21, no. 9 (September 1998): 616. http://dx.doi.org/10.1002/clc.4960210902.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

44

Nassar, Munir E. "Viagra®, the latest cardio-vascular drug." Clinical Cardiology 22, no. 1 (January 1999): 2. http://dx.doi.org/10.1002/clc.4960220103.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

45

Misgeld, Berno J. E., Rajib Mondal, and Steffen Leonhardt. "Pulsatile cerebrospinal model with cardio-vascular coupling." IFAC-PapersOnLine 48, no. 20 (2015): 183–88. http://dx.doi.org/10.1016/j.ifacol.2015.10.136.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

46

Aykan, Ahmet Çağrı, Engin Hatem, Ezgi Kalaycıoğlu, Tayyar Gökdeniz, and Can Yucel Karabay. "Assessment of arterial stiffness in patients with venous thromboembolism: Separate or continuous circuits?" Phlebology: The Journal of Venous Disease 32, no. 5 (May 27, 2016): 316–21. http://dx.doi.org/10.1177/0268355516652033.

Повний текст джерела

Анотація:

Objectives The aim of this study is to evaluate the association of venous thromboembolism with arterial stiffness by cardio-ankle vascular index method. Method We included 52 patients with a documented lower extremity venous thromboembolism within the last six months and 52 healthy subjects to this cross sectional observational study. Results Cardio-ankle vascular index (8.58 ± 1.60 versus 7.05 ± 1.44, p < 0.001, respectively) and systolic blood pressure (128.02 ± 7.13 mmHg versus 123.94 ± 8.12 mmHg, p = 0.008, respectively) were significantly higher among patients with venous thromboembolism than controls. Cardio-ankle vascular index was an independent predictor of venous thromboembolism in multivariate logistic regression analysis (p < 0.001, odds ratio = 1.864, 95% confidence interval = 1.370–2.536). Cardio-ankle vascular index value > 7.8 had a sensitivity of 82.7% and a specificity of 80.8% for predicting venous thromboembolism (area under curve = 0.789, 95% confidence interval = 0.698–0.863, p < 0.001) in receiver operating characteristic curve analysis. Conclusion We found that arterial stiffness was increased in patients with venous thromboembolism which highlights the fact that arterial and venous circulation is in continuum and an insult may affect both of these circuits.

Стилі APA, Harvard, Vancouver, ISO та ін.

47

Lakhonina, A. I., E. A. Aydinova, M. S. Brynza, D. V. Safronov, and I. V. Belozоrov. "Neurac (Neuromuscular Activation) in cardio-vascular rehabilitation for patients with arterial hypertension." Physical rehabilitation and recreational health technologies 5, no. 3 (September 30, 2020): 21–25. http://dx.doi.org/10.15391/prrht.2020-5(3).03.

Повний текст джерела

Анотація:

The aim of the study: Studying influence of Neurac method on control of blood pressure in patiens with arterial hypertension. Materials and methods: For the group amount of 15 patients with arterial hypertension stage 1-2 the Neurac method was used like rehabilitation tool for treatment. Results: 65% of patients had positive response for provided treatment. For 30% of patients it was possible to reduce the dose of the medications. Conclusions: Providing of Neurac method as a non-drug treatment tool for patients with arterial hypertension helps to improve life quality of the patients, reduce the dose of antihypertensive drugs in non-invasive way.

Стилі APA, Harvard, Vancouver, ISO та ін.

48

Bilyayeva, O. O., and I. V. Karol. "Investigation of the functional state changes of cardio-vascular system in patients, suffering peritonitis." Klinicheskaia khirurgiia 87, no. 11-12 (December 28, 2020): 23–27. http://dx.doi.org/10.26779/2522-1396.2020.11-12.23.

Повний текст джерела

Анотація:

Objective. To study a functional state of cardio-vascular system in patients, suffering peritonitis. Materials and methods. Analysis of dynamics in the electrocardiogram changes in 166 patients, including 84 women and 82 men, was conducted for studying of functional state of cardio-vascular system in extended peritonitis. Results. Changes on electrocardiograms were non monotonous and depended on the peritonitis stage. In 28.3% patients diffuse changes in myocardium were observed, while in 43.9% - moderate. In 42.6% patients the disorders in metabolic processes in myocardium were revealed. Changes in conductivity and excitability were noted merely in half of the patients. Hypoxia was observed in 17.7% patients in reactive stage of peritonitis, in 32.0% - in a toxic, in 75.8% - in terminal. Tachycardia in a reactive stage of peritonitis was noted in 77.4% patients, in toxic one - in 89.3%, and in terminal - in 86.2% patients. In terminal stage of peritonitis in 13.8% patients bradycardia was noted. The blood supply disorders of various compartments of myocardium was revealed in 34.4% patients. Conclusion. Functional changes of cardio-vascular system in patients depends on stage of peritonitis. In all the patients, suffering peritonitis, medicinal correction of the cardio-vascular system work must be conducted, while its intensity depends on stage of peritonitis.

Стилі APA, Harvard, Vancouver, ISO та ін.

49

Mika, Adriana, Lukasz P. Halinski, Tomasz Sledzinski, Sylwia Malgorzewicz, Paulina Woloszyk, Jolanta Dardzinska, Alicja Debska-Slizien, and Michal Chmielewski. "Analysis of Serum Fatty Acids Profile in Kidney Transplant Recipients." Nutrients 13, no. 3 (February 28, 2021): 805. http://dx.doi.org/10.3390/nu13030805.

Повний текст джерела

Анотація:

Patients with end-stage kidney disease, treated with renal transplantation, are at increased risk of cardio-vascular disease (CVD) and cardio-vascular mortality. They are also characterized by an atherogenic dyslipidemia. Alterations of the fatty acids (FA) profile contribute to increased cardio-vascular risk in the general population. In the current study we test the hypothesis that kidney transplantation is associated with ab-normalities in FA profile. FA profile was analysed by gas chromatography–mass spectrometry in 198 renal transplant recipients, and 48 control subjects. The most profound differences between renal transplant patients and controls were related to the content of branched chain FA, monounsaturated FA, and n-6 polyunsaturated FA, respectively. The FA profile significantly separated the patients from the controls in the principal component analysis (PCA). The abnormalities of FA profile showed a tendency for normalization in long-term kidney recipients, as compared to patients with recent transplants. The n-3 PUFA content demonstrated a strong inverse association with the presence of inflammation. Most profound alterations of the FA profile were observed in patients with impaired graft function (glomerular filtration rate < 45 mL/min). The study demonstrated significant disorders of the FA profile in kidney transplant recipients, that might contribute to cardio-vascular risk in this vulnerable patient population.

Стилі APA, Harvard, Vancouver, ISO та ін.

50

Taraghi Talab, Younes, Morteza Azizi, and Hajar Aghaei. "The Effect of Forgiveness Therapy on the Mental Health of Cardiovascular Patients Admitted to the Alli-nasab Hospital in Tabriz." Spirituality Research in Health Sciences 1, no. 1 (April 13, 2023): 75–85. http://dx.doi.org/10.34172/srhs.2023.007.

Повний текст джерела

Анотація:

The purpose of this study was to investigate the effect of forgivness therapy on mental health among cardio-vascular patients hospitalized in Tabriz Alinasab Hospital. The research method was quasi-experimental with per-test and post-test design and a control group. The population of this study consisted of all cardio-vascular patients hospitalized in Tabriz alinasab hospital in September 2018. For the sample needed for the present study 24 people were selected from the population with an accessible sampling method and were replaced randomly into the experimental group (12 people) and control group (12 people). The experimental group was trained in forgiveness therapy for 6 sessions composed of 90 minutes. The control group didn’t receive any treatment. Both groups were assessed before and after the completion of experimental group’s treatment sessions by GHQ questionnaire.The data were described by mean and standard deviation, and hypothesis analyzed through the analysis of co-variance. The results of the statistical analysis of the present research revealed that forgiveness therapy training had an effect on mental health of cardio-vascular patients. Therefore, it is suggested to use forgiveness therapy training independently or in combination with other techniques to improve the mental health among cardio-vascular patients.

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!